Medicine & Life Sciences
Acute Myeloid Leukemia
100%
Cell Transplantation
90%
plerixafor octahydrochloride
81%
Lymphoma, Large B-Cell, Diffuse
78%
Allogeneic Cells
70%
Decitabine
65%
Hodgkin Disease
60%
Transplants
59%
Mantle-Cell Lymphoma
57%
Stem Cell Transplantation
54%
GATA2 Deficiency
51%
Hematopoietic Stem Cell Mobilization
48%
Rituximab
46%
Survival
45%
Lenalidomide
44%
Lymphoma
43%
Granulocyte Colony-Stimulating Factor
41%
Myelodysplastic Syndromes
40%
Natural Killer Cells
38%
Drug Therapy
38%
Follicular Lymphoma
38%
Tissue Donors
38%
Azacitidine
37%
Progression-Free Survival
36%
Autologous Transplantation
36%
Cytarabine
35%
Recurrence
35%
Therapeutics
34%
Stem Cells
32%
Interleukin-15
29%
belinostat
29%
Bendamustine Hydrochloride
28%
Chimeric Antigen Receptors
27%
Hematopoietic Stem Cell Transplantation
26%
Peripheral Blood Stem Cells
25%
Leukemia
24%
Confidence Intervals
24%
Peripheral T-Cell Lymphoma
23%
Non-Hodgkin's Lymphoma
23%
Bone Marrow
23%
ALT-803
22%
Homologous Transplantation
21%
Hematopoietic Stem Cells
21%
B-Cell Lymphoma
19%
Graft vs Host Disease
19%
PCI 32765
19%
Clofarabine
18%
Transplantation
18%
T-Lymphocytes
17%
Neoplasms
17%